BioSpace News Archive

Business

Navrogen Enters into CRADA with The U.S. National Cancer Institute for the Clinical Development of NAV-001, an Anti-Mesothelin Antibody-Drug Conjugate

Navrogen, Inc. announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with researchers at the U.S. National Cancer Institute (NCI), part of the National Institutes of Health.

November 7, 2022
·
2 min read
Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx(TM) in a Model of Acute Pericarditis

Results Demonstrate Significant Reduction in Pericardial Effusion and Thickness and Significant Suppression of Key Inflammatory Markers IL-1β and IL-6

November 7, 2022
·
10 min read
Spinal Muscular Atrophy Treatment Market Size to Hit USD 18.9 BN by 2030

According to Nova one advisor, the global Spinal Muscular Atrophy Treatment market was valued at USD 3.4 Billion in 2021 and it is expected to hit around USD 18.9 billion by 2030 with a CAGR of 18.7% during the forecast period 2022 to 2030.

November 7, 2022
·
9 min read
Orthobiologics Market Size, Growth, Demand, Opportunities & Forecast To 2030

According to Nova one advisor, the global Orthobiologics market was valued at USD 5.11 billion in 2021 and it is expected to hit around USD 7.18 billion by 2030 with a CAGR of 4.10% during the forecast period 2022 to 2030.

November 7, 2022
·
8 min read